Which company developed the Ozempic and Wegovy medicines?

Novo Nordisk developed the Ozempic and Wegovy medicines.

Novo Nordisk developed Ozempic and Wegovy, brand names for medicines based on semaglutide. Ozempic is approved for managing type 2 diabetes, while Wegovy is approved in several markets for chronic weight management alongside diet and physical activity. Their popularity helped make Novo Nordisk one of the world’s most valuable healthcare companies.

The company’s history is strongly connected to diabetes care. Novo Nordisk was formed in 1989 through the merger of two Danish companies, Novo Industri and Nordisk Gentofte. It became a major producer of insulin and later expanded into treatments for obesity and related conditions.

Ozempic and Wegovy are often confused with Mounjaro and Zepbound, which are associated with Eli Lilly and use tirzepatide. The medicines also belong to a broader class of incretin-based treatments. Brand availability, approved uses, and labeling vary by country, so a market-cap question should not be treated as medical advice.